QUELIMMUNE adoption drives four-fold increase in sequential quarter net revenue NEUTRALIZE AKI trial exceeds 50% enrollment, ...

While the occasional energy drink may seem harmless, regular consumption can have long-term consequences, particularly for ...

CalciMedica Inc. ("CalciMedica" or the "Company") , a clinical-stage biopharmaceutical company focused on developing novel calcium release-activated calcium (CRAC) channel inhibition therapies for ...

PPIs like omeprazole (Prilosec) and esomeprazole (Nexium) are widely used to treat heartburn and acid reflux. Long-term use ...

Precision Care Medicine students work with clinical faculty at Johns Hopkins Medicine to learn how to use machine learning ...

A study shows that leukemia cells drink up taurine, which is produced in the body and also consumed through foods and in energy drinks, and use it as fuel for growth. This highlights a potential to ...

New Drug Application (NDA) for hyperphosphatemia in chronic kidney disease patients on dialysis under review by FDA with PDUFA target action date of June 28, 2025; ongoing ...

BURLINGTON, Mass., May 14, 2025 (GLOBE NEWSWIRE) -- scPharmaceuticals Inc. (Nasdaq: SCPH) (the “Company”), a pharmaceutical company committed to revolutionizing cardiorenal healthcare through ...

During the monsoon, the risk of many types of mosquito-borne diseases increases significantly. Diseases like dengue, malaria, ...

Q1 2025 Earnings Call Transcript May 13, 2025 Operator: Good day, everyone, and welcome to Nuwellis First Quarter 2025 Earnings Conference Call. At this time, all participants are in a listen-only ...

Hoth Therapeutics announces positive preclinical results for HT-KIT, a precision antisense therapy targeting rare and aggressive KIT-driven cancers: New York Wednesday, May 14, 20 ...